Literature DB >> 22075169

Success of HPV vaccination is now a matter of coverage.

Mark Schiffman1, Sholom Wacholder.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 22075169     DOI: 10.1016/S1470-2045(11)70324-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  16 in total

1.  AACR Cancer Progress Report 2015.

Authors:  José Baselga; Nina Bhardwaj; Lewis C Cantley; Ronald DeMatteo; Raymond N DuBois; Margaret Foti; Susan M Gapstur; William C Hahn; Lee J Helman; Roy A Jensen; Electra D Paskett; Theodore S Lawrence; Stuart G Lutzker; Eva Szabo
Journal:  Clin Cancer Res       Date:  2015-10-01       Impact factor: 12.531

2.  The Need for Societal Investment to Improve Cervical Cancer Outcomes in Nigeria: A commentary.

Authors:  Jonah Musa
Journal:  Afr J Reprod Health       Date:  2017-12

Review 3.  Virus-like particles for the prevention of human papillomavirus-associated malignancies.

Authors:  Joshua W Wang; Richard B S Roden
Journal:  Expert Rev Vaccines       Date:  2013-02       Impact factor: 5.217

Review 4.  Toll-like receptors and B cells: functions and mechanisms.

Authors:  Claire M Buchta; Gail A Bishop
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

5.  Achieving high coverage in Rwanda's national human papillomavirus vaccination programme.

Authors:  Agnes Binagwaho; Claire M Wagner; Maurice Gatera; Corine Karema; Cameron T Nutt; Fidele Ngabo
Journal:  Bull World Health Organ       Date:  2012-05-23       Impact factor: 9.408

6.  Engaging Pattern Recognition Receptors in Solid Tumors to Generate Systemic Antitumor Immunity.

Authors:  Michael Brown
Journal:  Cancer Treat Res       Date:  2022

7.  Further exploration of the structure-activity relationship of imidazoquinolines; identification of potent C7-substituted imidazoquinolines.

Authors:  Jordan R Hunt; Peter A Kleindl; K Ryan Moulder; Thomas E Prisinzano; M Laird Forrest
Journal:  Bioorg Med Chem Lett       Date:  2019-11-09       Impact factor: 2.823

8.  Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Lorenzo Galluzzi; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

9.  Parental acceptance of HPV vaccine in Peru: a decision framework.

Authors:  Rosario M Bartolini; Jennifer L Winkler; Mary E Penny; D Scott LaMontagne
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

Review 10.  Therapeutic cancer vaccines: past, present, and future.

Authors:  Chunqing Guo; Masoud H Manjili; John R Subjeck; Devanand Sarkar; Paul B Fisher; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.